Literature DB >> 21971401

Gas1 interferes with AβPP trafficking by facilitating the accumulation of immature AβPP in endoplasmic reticulum-associated raft subdomains.

Julien Chapuis1, Valérie Vingtdeux, Hemachander Capiralla, Peter Davies, Philippe Marambaud.   

Abstract

The amyloid-β protein precursor (AβPP) is a type I transmembrane protein that undergoes maturation during trafficking in the secretory pathway. Proper maturation and trafficking of AβPP are necessary prerequisites for AβPP processing to generate amyloid-β (Aβ), the core component of Alzheimer's disease senile plaques. Recently, we reported that the glycosylphosphatidylinositol (GPI)-anchored protein growth arrest-specific 1 (Gas1) binds to and interferes with the maturation and processing of AβPP. Gas1 expression led to a trafficking blockade of AβPP between the endoplasmic reticulum (ER) and the Golgi. GPI-anchored proteins can exit the ER by transiting through raft subdomains acting as specialized sorting platforms. Here, we show that Gas1 co-partitioned and formed a complex with AβPP in raft fractions, wherein Gas1 overexpression triggered immature AβPP accumulation. Pharmacological interference of ER to Golgi transport increased immature AβPP accumulation upon Gas1 expression in these raft fractions, which were found to be positive for the COPII protein complex component Sec31A, a specific marker for ER exit sites. Furthermore, a Gas1 mutant lacking the GPI anchor that could not transit through rafts was still able to form a complex with AβPP but did not lead to immature AβPP accumulation in rafts. Together these data show that Gas1 interfered with AβPP trafficking by interacting with AβPP to facilitate its translocation into specialized ER-associated rafts where immature AβPP accumulated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21971401      PMCID: PMC3309423          DOI: 10.3233/JAD-2011-110434

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  46 in total

Review 1.  Alzheimer's disease: strategies for disease modification.

Authors:  Martin Citron
Journal:  Nat Rev Drug Discov       Date:  2010-05       Impact factor: 84.694

Review 2.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

3.  A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.

Authors:  Ute Dreses-Werringloer; Jean-Charles Lambert; Valérie Vingtdeux; Haitian Zhao; Horia Vais; Adam Siebert; Ankit Jain; Jeremy Koppel; Anne Rovelet-Lecrux; Didier Hannequin; Florence Pasquier; Daniela Galimberti; Elio Scarpini; David Mann; Corinne Lendon; Dominique Campion; Philippe Amouyel; Peter Davies; J Kevin Foskett; Fabien Campagne; Philippe Marambaud
Journal:  Cell       Date:  2008-06-27       Impact factor: 41.582

4.  CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease.

Authors:  Jeremy Koppel; Fabien Campagne; Valérie Vingtdeux; Ute Dreses-Werringloer; Michael Ewers; Dan Rujescu; Harald Hampel; Marc L Gordon; Erica Christen; Julien Chapuis; Blaine S Greenwald; Peter Davies; Philippe Marambaud
Journal:  Mol Med       Date:  2011-05-24       Impact factor: 6.354

5.  Selective export of human GPI-anchored proteins from the endoplasmic reticulum.

Authors:  Carine Bonnon; Markus W Wendeler; Jean-Pierre Paccaud; Hans-Peter Hauri
Journal:  J Cell Sci       Date:  2010-04-27       Impact factor: 5.285

Review 6.  Is GAS1 a co-receptor for the GDNF family of ligands?

Authors:  Ora Schueler-Furman; Eitan Glick; José Segovia; Michal Linial
Journal:  Trends Pharmacol Sci       Date:  2006-01-06       Impact factor: 14.819

7.  Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levels.

Authors:  John S K Kauwe; Carlos Cruchaga; Sarah Bertelsen; Kevin Mayo; Wayne Latu; Petra Nowotny; Anthony L Hinrichs; Anne M Fagan; David M Holtzman; Alison M Goate
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 8.  Growth arrest specific gene 1: a fuel for driving growth in the cerebellum.

Authors:  Gregory Marques; Chen-Ming Fan
Journal:  Cerebellum       Date:  2002-12       Impact factor: 3.847

Review 9.  Amyloid precursor protein trafficking, processing, and function.

Authors:  Gopal Thinakaran; Edward H Koo
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

10.  Glial cell line-derived neurotrophic factor-dependent recruitment of Ret into lipid rafts enhances signaling by partitioning Ret from proteasome-dependent degradation.

Authors:  Brian A Pierchala; Jeffrey Milbrandt; Eugene M Johnson
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

View more
  2 in total

1.  Expression of Gas1 in Mouse Brain: Release and Role in Neuronal Differentiation.

Authors:  Elizabeth Bautista; Natanael Zarco; Nicolás Aguirre-Pineda; Manuel Lara-Lozano; Paula Vergara; Juan Antonio González-Barrios; Raúl Aguilar-Roblero; José Segovia
Journal:  Cell Mol Neurobiol       Date:  2017-11-06       Impact factor: 5.046

2.  Growth arrest specific 1 (GAS1) is abundantly expressed in the adult mouse central nervous system.

Authors:  Natanael Zarco; Elizabeth Bautista; Manola Cuéllar; Paula Vergara; Paola Flores-Rodriguez; Raúl Aguilar-Roblero; José Segovia
Journal:  J Histochem Cytochem       Date:  2013-06-27       Impact factor: 2.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.